Soluble beta-amyloid induces Alzheimer's disease features in human fibroblasts and in neuronal tissues.

It has been shown that K+ channels, Cp20 (a 20kD GTP-binding protein), and intracellular calcium release, play a key role in associative memory storage. These same elements have been shown to be altered in fibroblasts from Alzheimer's Disease (AD) patients. In addition, it has been shown that PKC, also implicated in memory storage and closely related to the above mentioned components, is also altered in AD fibroblasts. Moreover, beta-amyloid was capable of inducing an AD-like phenotype for K+ channels and Cp20 in otherwise normal fibroblasts, providing additional evidence for the potential involvement of these components in AD and suggesting a possible pathological consequence of soluble beta-amyloid elevation in AD. Preliminary evidence shows that comparable changes in potassium channel function are also present in human olfactory neuroblasts from AD patients. These results indicate that the observed changes not only occur in peripheral tissues such as fibroblasts, but also in neural tissue, the primary site of AD pathology.

[1]  S. Rapoport,et al.  β-amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease , 1994, Brain Research.

[2]  M. Mattson,et al.  Activation of K+ channels and suppression of neuronal activity by secreted β-amyloid-precursor protein , 1996, Nature.

[3]  C. Masters,et al.  β A4 amyloid protein and its precursor in Alzheimer's disease , 1992 .

[4]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  M. A. Simmons,et al.  Amyloid β peptides act directly on single neurons , 1993, Neuroscience Letters.

[6]  T. Good,et al.  Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. , 1996, Biophysical journal.

[7]  J. Blass,et al.  Diminished mitogen-induced calcium uptake by lymphocytes from alzheimer patients , 1987, Biological Psychiatry.

[8]  D L Alkon,et al.  Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels. , 1994, Science.

[9]  D. Selkoe,et al.  Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.

[10]  J. Goldman,et al.  Altered response of fibroblasts from aged and Alzheimer donors to drugs that elevate cytosolic free calcium , 1988, Neurobiology of Aging.

[11]  B. Regland,et al.  The role of amyloid β-protein in Alzheimer's disease , 1992, The Lancet.

[12]  L. Nee,et al.  A family with histologically confirmed Alzheimer's disease. , 1983, Archives of neurology.

[13]  D L Alkon,et al.  Voltage-clamp analysis of the effects of classical conditioning on the hippocampus. , 1991, Journal of neurophysiology.

[14]  F. Maxfield,et al.  Resting [Ca2+]i and [Ca2+]i transients are similar in fibroblasts from normal and Alzheimer's donors , 1992, Neurobiology of Aging.

[15]  J. Seegmiller,et al.  Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine Synthesis , 1967, Science.

[16]  D. Selkoe.  The molecular pathology of Alzheimer's disease , 1991, Neuron.

[17]  D L Alkon,et al.  Inositol trisphosphate regulation of photoreceptor membrane currents. , 1986, Biophysical journal.

[18]  G. Gibson,et al.  Increased Inositol 1,4,5‐Trisphosphate Accumulation Correlates with an Up‐Regulation of Bradykinin Receptors in Alzheimer's Disease , 1995, Journal of neurochemistry.

[19]  J. O'brien,et al.  Tay-Sachs Disease: Generalized Absence of a Beta-D-N-Acetylhexosaminidase Component , 1969, Science.

[20]  R. Mullins,et al.  Serum- and bradykinin-induced calcium transients in familial Alzheimer's fibroblasts , 1993, Neurobiology of Aging.

[21]  Daniel L. Alkon,et al.  Memory Traces in the Brain , 1987 .